apofen

What apofen does

apofen is a non-profit organization that supports people affected by phenylketonuria (PKU) and other inherited metabolic disorders. Based on its .pt domain, the organization operates in Portugal and appears to function as a patient advocacy and support association for a rare disease community. As a non-profit, apofen likely operates on a donation, membership, and grant-funded model rather than a commercial revenue model, though no financial disclosures, donor base, or grant history are documented in the source data.

The source provides no substantive information on apofen's products, services, technology stack, or programmatic activities. The organization's website (apofen.pt) returns only a loading/verification placeholder page containing no detailed content about services offered, member benefits, advocacy campaigns, or partnerships with healthcare providers, research institutions, or pharmaceutical companies. No headcount, office locations, management team, or operational milestones are available.

There is no evidence of funding rounds, mergers, acquisitions, regulatory actions, partnerships, or any other corporate structural moves. The data inventory shows empty arrays across headcount, products, customers, partnerships, management, funding, and regulatory categories. As a result, this description is constrained to the verified facts: apofen is a Portuguese non-profit serving the PKU and inherited metabolic disorders patient community, with no further operational details disclosed in the available source material.

Name

apofen

Website

https://apofen.pt

Company type

Private

Operating status

Operating

Short description

apofen is a Portuguese non-profit organization that supports people affected by phenylketonuria (PKU) and other inherited metabolic disorders, serving as a patient advocacy and community resource for this rare disease population.

Ownership category

akta.pro rank

Product category

Rare Disease Patient Support

NAICS

Voluntary Health Organizations (813212), Social Advocacy Organizations (8133)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYHLAIAIAJ

Rare Endocrine & Growth Disorder Therapies

Healthcare & Life Sciences/Pharmaceuticals/Orphan & Rare Disease Pharmaceuticals

Keywords

• Phenylketonuria support
• Inherited metabolic disorders
• Rare disease advocacy
• Patient support services
• Non-profit health association

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Others

Core offering

apofen is a non-profit organization that supports people affected by phenylketonuria (PKU) and other inherited metabolic disorders. The organization operates in the patient-support and rare-disease advocacy space, with no specific commercial products or paid services evidenced in the available source data.

Differentiator

Problem solved

Functional benefit

Products and services

• Patient support for phenylketonuria and inherited metabolic disorders Non-profit support service for individuals and families affected by phenylketonuria (PKU) and other inherited metabolic disorders.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• E.S.PKU (European Society for Phenylketonuria and Allied Disorders): Pan-European patient and clinical network dedicated to PKU and allied metabolic disorders. Directly comparable to apofen in disease focus (PKU) and advocacy mission, with a broader geographic footprint.
• National PKU Alliance (NPKUA): U.S.-based patient advocacy organization supporting individuals and families affected by PKU. Closely comparable mission — PKU-specific support, education, and research advocacy — though serving a different national market.
• Metabolic Support UK: UK charity supporting people affected by inherited metabolic disorders, including PKU. Comparable patient-support mission across the same disease cluster, though operating at greater scale in a larger country.
• Save Babies Through Screening Foundation: U.S.-based advocacy organization promoting newborn screening — the upstream mechanism through which most PKU cases are identified. Highly relevant peer because apofen's beneficiary pipeline depends on the same screening infrastructure this group advocates for.

Regional players

• AsPKU (Asociación Española de PKU y otros Trastornos Metabólicos): Spanish patient association for PKU and related metabolic disorders. Highly comparable disease focus and advocacy model to apofen, serving the neighboring Iberian market rather than Portugal directly.
• Canadian PKU and Allied Disorders (CanPKU): Canadian non-profit supporting individuals and families affected by PKU and allied metabolic disorders. Mission-equivalent peer organization operating in a different national market, useful as a comparable organizational model.

Broad incumbents

• EURORDIS – Rare Diseases Europe: Europe-wide alliance of rare-disease patient organizations covering thousands of conditions including PKU. Broader incumbent that apofen could affiliate with to access EU funding, policy influence, and cross-disease advocacy infrastructure.
• National Organization for Rare Disorders (NORD): U.S.-based umbrella advocacy organization for all rare diseases. Operates adjacent to apofen's space at much larger scale and offers a model for how a small disease-focused body could scale into a broader advocacy platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat1 record

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about apofen